8-K - Quince Therapeutics, Inc. (0001662774) (Filer)
Published . Updated .
Filed: 2026-10-06 AccNo: 0001193125-26-415730 Size: 567 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Directly affected
- QNCX QUINCE THERAPEUTICS INC COM PA
SEC 8-K filing -> direct issuer disclosure -> QNCX
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-06 AccNo: 0001193125-26-415730 Size: 567 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments t…
Source: sec-edgar
Quince Therapeutics (QNCX) since “8-K - Quince Therapeutics, Inc. (0001662774) (Filer),” compared with the market
Since the first closing price after “8-K - Quince Therapeutics, Inc. (0001662774) (Filer),” Quince Therapeutics (QNCX) is +6.16%. The S&P 500 fund (SPY) is -0.94% over the same days, a +7.10% difference versus the market.
Who gains and who loses around Quince Therapeutics (QNCX)
Companies mentioned with this story
- QNCX Quince Therapeutics
For “8-K - Quince Therapeutics, Inc. (0001662774) (Filer),” Quince Therapeutics (QNCX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> QNCX
How “8-K - Quince Therapeutics, Inc. (0001662774) (Filer)” reaches Quince Therapeutics (QNCX)
Quince Therapeutics (QNCX) is the company in “8-K - Quince Therapeutics, Inc. (0001662774) (Filer),” the 7 Oct 2026 this story story.
For Quince Therapeutics (QNCX), the reason on file says SEC 8-K filing -> direct issuer disclosure -> QNCX
Dates and price levels for Quince Therapeutics (QNCX)
QNCX traded between 26.23 and 36.26 across 12 sessions. The latest close on file is 31.30.
A simple score for Quince Therapeutics (QNCX)
14 out of 100
“8-K - Quince Therapeutics, Inc. (0001662774) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.